4574.T
TAIKO PHARMACEUTICAL CO.,LTD.
プライム · 医薬品 · 医薬品 · JP
JPY 254.00
−1.17%Year over year
Reported trailing growth
- Revenue
- +1.7%
- EBITDA
- —
- EBIT
- -27.0%
- EPS
- +2.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -1.5%
- EBITDA
- —
- EPS
- -37.2%
Three-year CAGR
- Revenue
- +8.3%
- EBITDA
- -18.2%
- EBIT
- -27.0%
- Net income
- +2.8%
- EPS
- +2.7%
- Free cash flow
- +155.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026